| | | | | | | |
 | MODERNA, INC. | -1.72% | -8.50% | -5.21% | 4.45% | 756.49% | 66 559 |
| IQVIA HOLDINGS INC. | -2.05% | 3.36% | 13.38% | -7.04% | 44.71% | 44 054 |
| ALNYLAM PHARMACEUTICALS, INC. | -3.96% | 0.86% | -5.68% | 54.13% | 83.78% | 28 711 |
| SEAGEN INC. | -1.45% | -2.84% | 5.83% | -1.40% | 14.63% | 25 622 |
| ICON PUBLIC LIMITED COMPANY | -2.57% | 6.91% | 22.39% | -10.97% | 38.81% | 19 923 |
 | CELLTRION, INC. | -1.66% | 2.91% | 3.61% | 9.12% | 4.31% | 19 489 |
 | HANGZHOU TIGERMED CONSULTING CO., LTD. | -4.14% | -2.32% | 8.40% | 10.00% | 47.00% | 14 671 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | -1.37% | 2.98% | 13.31% | -26.44% | 55.22% | 12 737 |
| BIO-TECHNE CORPORATION | -4.54% | -2.50% | -8.82% | -26.29% | 47.92% | 12 426 |
| PHARMARON BEIJING CO., LTD. | -4.98% | -4.31% | 4.41% | -9.93% | 89.17% | 12 421 |
| UNITED THERAPEUTICS CORPORATION | 0.97% | -1.34% | -8.22% | 26.61% | 151.62% | 11 522 |
| QIAGEN N.V. | -0.46% | 0.49% | -1.12% | -0.92% | 37.93% | 11 280 |
 | GENSCRIPT BIOTECH CORPORATION | 1.39% | -6.98% | 2.41% | -4.32% | 33.53% | 7 360 |
| MEDPACE HOLDINGS, INC. | -1.87% | 5.54% | 9.07% | 34.89% | 143.91% | 7 323 |
 | BACHEM HOLDING AG | -1.53% | -1.65% | 0.75% | -25.92% | 122.98% | 6 946 |
| | | | | | | |
| | Media | -2.00% | -0.49% | 3.63% | 1.73% | 111.47% | |
| | Media ponderata per Capi. | -2.14% | -1.28% | 3.21% | 3.87% | 210.55% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
